Literature DB >> 12860862

Normal values of B type natriuretic peptide in infants, children, and adolescents.

A Koch1, H Singer.   

Abstract

OBJECTIVE: To determine normal values of plasma B type natriuretic peptide from infancy to adolescence using a commercially available rapid assay.
SETTING: Tertiary referral centre.
DESIGN: The study was cross sectional. Plasma BNP concentration was measured in 195 healthy infants, children, and adolescents from birth to 17.6 years using the triage BNP assay (a fluorescence immunoassay).
RESULTS: During the first week of life, the mean (SD) plasma concentration of BNP in newborn infants decreased significantly from 231.6 (197.5) to 48.4 (49.1) pg/ml (p = 0.001). In all subjects older than two weeks plasma BNP concentration was less than 32.7 pg/ml. There was no significant difference in mean plasma BNP measured in boys and girls younger than 10 years (8.3 (6.9) v 8.5 (7.5) pg/ml). In contrast, plasma concentration of BNP in girls aged 10 years or older was significantly higher than in boys of the same age group (12.1 (9.6) v 5.1 (3.5) pg/ml, p < 0.001). Plasma BNP concentrations were higher in pubertal than in prepubertal girls (14.4 (9.7) v 7.1 (6.6) pg/ml, p < 0.001) and were correlated with the Tanner stage (r = 0.41, p = 0.001).
CONCLUSIONS: Plasma BNP concentrations in newborn infants are relatively high, vary greatly, and decrease rapidly during the first week of life. In children older than 2 weeks, the mean plasma concentration of BNP is lower than in adults. There is a sex related difference in the second decade of life, with higher BNP concentrations in girls. BNP concentrations in girls are related to pubertal stage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860862      PMCID: PMC1767791          DOI: 10.1136/heart.89.8.875

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  29 in total

1.  Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide.

Authors:  Y Fischer; K Filzmaier; H Stiegler; J Graf; S Fuhs; A Franke; U Janssens; A M Gressner
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

Review 2.  Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin.

Authors:  P R Kalra; S D Anker; A J Coats
Journal:  Cardiovasc Res       Date:  2001-08-15       Impact factor: 10.787

3.  Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction.

Authors:  J G Crilley; M Farrer
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

4.  Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants.

Authors:  H Holmström; C Hall; E Thaulow
Journal:  Acta Paediatr       Date:  2001-02       Impact factor: 2.299

5.  Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only.

Authors:  Allan D Struthers
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

6.  B-type natriuretic peptide (BNP)--validation of an immediate response assay.

Authors:  M Vogeser; K Jacob
Journal:  Clin Lab       Date:  2001       Impact factor: 1.138

7.  Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.

Authors:  Q Dao; P Krishnaswamy; R Kazanegra; A Harrison; R Amirnovin; L Lenert; P Clopton; J Alberto; P Hlavin; A S Maisel
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

8.  Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease.

Authors:  T Kawamura; M Wago; H Kawaguchi; M Tahara; M Yuge
Journal:  Pediatr Int       Date:  2000-06       Impact factor: 1.524

9.  Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide.

Authors:  Matthew McNairy; Nancy Gardetto; Paul Clopton; Alex Garcia; Padma Krishnaswamy; Radmila Kazanegra; Michael Ziegler; Alan S Maisel
Journal:  Am Heart J       Date:  2002-03       Impact factor: 4.749

10.  Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease.

Authors:  Takashi Kawamura; Masakuni Wago
Journal:  Cardiol Young       Date:  2002-03       Impact factor: 1.093

View more
  62 in total

1.  Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery.

Authors:  T S Mir; C Haun; C Lilje; S Läer; J Weil
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

2.  Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease.

Authors:  J G Berry; B Askovich; R E Shaddy; J A Hawkins; C G Cowley
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.655

3.  Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children.

Authors:  L Schwachtgen; M Herrmann; T Georg; P Schwarz; N Marx; A Lindinger
Journal:  Z Kardiol       Date:  2005-06

4.  Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals.

Authors:  Steven J Soldin; Offie P Soldin; Alanna J Boyajian; Madeline S Taskier
Journal:  Clin Chim Acta       Date:  2005-12-19       Impact factor: 3.786

5.  Clinical relevance of different B-type natriuretic peptide decisional cutoff values for the diagnosis of congenital heart disease in the first weeks of life.

Authors:  Cantinotti Massimiliano; Storti Simona; Murzi Bruno; Clerico Aldo; Bibhuti B Das
Journal:  Pediatr Cardiol       Date:  2011-04       Impact factor: 1.655

6.  Factors associated with serum B-type natriuretic peptide in infants with single ventricles.

Authors:  Ryan J Butts; Victor Zak; Daphne Hsu; James Cnota; Steven D Colan; David Hehir; Paul Kantor; Jami C Levine; Renee Margossian; Marc Richmond; Anita Szwast; Derek Williams; Richard Williams; Andrew M Atz
Journal:  Pediatr Cardiol       Date:  2014-02-13       Impact factor: 1.655

7.  Early elevations in B-type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injury.

Authors:  Bhupinder Reel; Peter E Oishi; Jong-Hau Hsu; Ginny Gildengorin; Michael A Matthay; Jeffrey R Fineman; Heidi Flori
Journal:  Pediatr Pulmonol       Date:  2009-11

8.  Serum Levels of Natriuretic Peptides in Children before and after Treatment for an Atrial Septal Defect, a Patent Ductus Arteriosus, and a Coarctation of the Aorta-A Prospective Study.

Authors:  Anneli Eerola; Eero Jokinen; Talvikki Boldt; Ilkka P Mattila; Jaana I Pihkala
Journal:  Int J Pediatr       Date:  2010-04-20

9.  Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts.

Authors:  Ozlem Elkiran; Ayse Sandikkaya; Gulendam Kocak; Cemsit Karakurt; Cagatay Taskapan; Saim Yologlu
Journal:  Pediatr Cardiol       Date:  2013-03-13       Impact factor: 1.655

10.  Saw-tooth cardiomyopathy.

Authors:  Periklis A Davlouros; Peter G Danias; Ageliki A Karatza; Maria G Kiaffas; Dimitrios Alexopoulos
Journal:  J Cardiovasc Magn Reson       Date:  2009-12-16       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.